Pasireotide Diaspartate | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pasireotide Diaspartate
FDF Dossiers

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Pasireotide Diaspartate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 3 FDA Orange Book, 3 Canada

6 FDF Dossiers
3 FDA Orange Book
3 Canada

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML), SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML), SOLUTION;SUBCUTANEOUS - EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)

SOLUTION;SUBCUTANEOUS - EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML)
SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML)
SOLUTION;SUBCUTANEOUS - EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

PATENTS & EXCLUSIVITIES

6 US Patents, 9 Health Canada Patents

6 US Patents
9 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 3Recordati

02 3Recordati Rare Diseases

filter Dosage Reset all filters

6 All

01 3SOLUTION

02 3SOLUTION;SUBCUTANEOUS

filter Regulatory Info Reset all filters

6 All

01 3RX

02 3Blank

filter Brand Name Reset all filters

6 All

01 6SIGNIFOR

filter Country Reset all filters

6 All

01 3Canada

02 3USA

List of Suppliers

Product Main Page

01

Recordati

BioAsia

Not Confirmed

Recordati

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

PASIREOTIDE DIASPARTATE

Brand Name : SIGNIFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML)

Packaging :

Approval Date : 2012-12-14

Application Number : 200677

Regulatory Info : RX

Registration Country : USA

Product Web Link

Digital Content

Corporate PDF

02

Recordati

BioAsia

Not Confirmed

Recordati

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

PASIREOTIDE DIASPARTATE

Brand Name : SIGNIFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML)

Packaging :

Approval Date : 2012-12-14

Application Number : 200677

Regulatory Info : RX

Registration Country : USA

Product Web Link

Digital Content

Corporate PDF

03

Recordati

BioAsia

Not Confirmed

Recordati

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

PASIREOTIDE DIASPARTATE

Brand Name : SIGNIFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)

Packaging :

Approval Date : 2012-12-14

Application Number : 200677

Regulatory Info : RX

Registration Country : USA

Product Web Link

Digital Content

Corporate PDF

04

Recordati Rare Diseases

BioAsia

Not Confirmed

Recordati Rare Diseases

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

PASIREOTIDE (PASIREOTIDE DIASPARTATE)

Brand Name : SIGNIFOR

Dosage Form : SOLUTION

Dosage Strength : 0.3MG/ML

Packaging : 30/60

Approval Date :

Application Number : 2413299

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Recordati Rare Diseases

BioAsia

Not Confirmed

Recordati Rare Diseases

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

PASIREOTIDE (PASIREOTIDE DIASPARTATE)

Brand Name : SIGNIFOR

Dosage Form : SOLUTION

Dosage Strength : 0.6MG/ML

Packaging : 60

Approval Date :

Application Number : 2413302

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Recordati Rare Diseases

BioAsia

Not Confirmed

Recordati Rare Diseases

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

PASIREOTIDE (PASIREOTIDE DIASPARTATE)

Brand Name : SIGNIFOR

Dosage Form : SOLUTION

Dosage Strength : 0.9MG/ML

Packaging : 60

Approval Date :

Application Number : 2413310

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!